ATP Life Science Ventures, L.P.

Other

US·SEC (Form 4)

Stoke Therapeutics, Inc.Akero Therapeutics, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by ATP Life Science Ventures, L.P.. Director active across 2 companies, notably Stoke Therapeutics, Inc.. Aggregated, 4 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.

Declarations4 total

Executives●JSStoke Therapeutics, Inc.3SEC

A

ATP Life Science Ventures, L.P.

17,161,713 shares

Common Stock

SEC:0001062993-21-006113·28 Jun 2021

SEC ↗

Executives●JAAkero Therapeutics, Inc.3SEC

A

ATP Life Science Ventures, L.P.

5,830,203 shares